Revision notes โบ Post-op care & complications
Venous thromboembolism prophylaxis in orthopaedics
Venous thromboembolism, including deep vein thrombosis and pulmonary embolism, is a preventable cause of death after orthopaedic surgery and injury. UK practice follows NICE guidance, balancing the risk of clotting against the risk of bleeding for each patient.
Key points
- Every admitted orthopaedic patient needs documented VTE and bleeding risk assessment.
- Virchow's triad: stasis, endothelial injury and hypercoagulability.
- Hip replacement: LMWH 10 days then aspirin 28 days, LMWH 28 days, or rivaroxaban (NICE NG89).
- Knee replacement: aspirin 14 days, LMWH 14 days, or rivaroxaban (NICE NG89).
- Hip fracture: LMWH or fondaparinux for one month if bleeding risk is acceptable.
- Lower limb immobilisation: consider prophylaxis after individual risk assessment.
- Use mechanical prophylaxis when pharmacological prophylaxis is contraindicated.
The basics
Venous thromboembolism (VTE) includes deep vein thrombosis (DVT) and pulmonary embolism (PE). Orthopaedic patients are at high risk because of reduced mobility, surgery, lower limb immobilisation and injury.
Virchow's triad explains why:
- Venous stasis: immobility, tourniquets, casts, positioning.
- Endothelial injury: surgery and trauma, particularly femoral manipulation in hip arthroplasty.
- Hypercoagulability: the response to surgery and trauma, malignancy, oestrogen-containing medication, pregnancy and inherited thrombophilia.
Hip and knee arthroplasty, hip fracture surgery, major trauma, pelvic fractures and spinal cord injury carry the highest risk. VTE prevention is a patient safety priority and every admitted patient should have a documented risk assessment.
Assessment
Assess all patients on admission (and when their condition changes) for VTE risk and bleeding risk, using a national tool such as the Department of Health VTE risk assessment tool.
VTE risk factors include active cancer, previous VTE, age over 60, obesity, critical care admission, dehydration, known thrombophilia, significant medical comorbidity, oestrogen therapy, varicose veins with phlebitis, pregnancy or postpartum, and expected significant reduction in mobility.
Bleeding risk factors include active bleeding, acquired or inherited bleeding disorders, current anticoagulation, acute stroke, thrombocytopenia, uncontrolled hypertension, recent neurosurgery or spinal procedures, and procedures with a high bleeding risk.
Clinical suspicion of DVT: unilateral leg swelling, pain and tenderness; of PE: breathlessness, pleuritic chest pain, tachycardia, hypoxia or collapse. Use the Wells score and D-dimer (less useful post-operatively because it is raised after surgery), with proximal leg ultrasound or CT pulmonary angiography.
Never miss
- Sudden breathlessness, chest pain, hypoxia or collapse after surgery: treat as PE until proven otherwise.
- Falling platelets with new thrombosis on heparin: suspect HIT and stop heparin.
- Back pain and new leg weakness after neuraxial block on anticoagulation: urgent MRI for spinal haematoma.
Common pitfalls
- Forgetting to reassess risk when the clinical situation changes.
- Applying stockings in peripheral arterial disease or neuropathy.
- Relying on D-dimer after surgery, when it is almost always raised.
- Mistiming anticoagulant doses around spinal anaesthesia or catheter removal.
- Overlooking heparin-induced thrombocytopenia when platelets fall and new clots appear.
Read the full note (5 more sections) and test yourself
Free for everyone, no card: exam-style questions on venous thromboembolism prophylaxis in orthopaedics with every option explained, real X-rays, and a Consultant on Call to explain anything you get wrong.
Create a free account โ Log inFurther reading: ["NICE NG89. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. 2018 (updated 2019).","Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin. Lancet. 2000.","CRISTAL Study Group. Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty. JAMA. 2022.","van Adrichem RA, et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting (POT-KAST and POT-CAST). N Engl J Med. 2017."]
โ All revision notes ยท Question of the day ยท X-ray of the day